Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Colorectal Neoplasms 6 Uterine Cervical Neoplasms 4 Breast Neoplasms 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Warts 1 Urinary Bladder Neoplasms 1 Tinea 1 Skin Neoplasms 1 Retinoblastoma 1 Pulmonary Atelectasis 1 Postoperative Complications 1 Pneumonia 1 Papillomavirus Infections 1 Oncology Problem 1 Nevus 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Kidney Failure, Chronic 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Heart Diseases 1

Interventions

Therapeutics 21 Psychiatric Rehabilitation 20 Surveys and Questionnaires 7 Early Intervention, Educational 6 Counseling 6 Yoga 5 Psychosocial Intervention 5 Cognitive Behavioral Therapy 5 Behavior Therapy 5 Mindfulness 4 Ketamine 4 Exercise 4 Escitalopram 4 Acupuncture Therapy 4 Saline Solution 3 Psilocybin 3 Mindfulness-Based Stress Reduction 3 Mindfulness-Based Cognitive Therapy 3 Methods 3 Exercise Therapy 3 Control Groups 3 Citalopram 3 Chemotherapy, Adjuvant 3 Sugars 2 Sertraline 2 Palliative Care 2 Observation 2 Niacin 2 Mental Status and Dementia Tests 2 Interviews as Topic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Depression × Mass Screening × Clear all

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡